Skip to main content
. 2020 Mar 9;50(4):349–356. doi: 10.1093/jjco/hyaa004

Table 6.

False-positive conditions of PSMA–PET in the diagnosis of prostate cancer

Physiological uptake
Head and neck Lacrimal gland, parotid gland, submandibular gland
Abdomen Liver, spleen, kidney, small bowel, ureter
Pelvis Urinary bladder, myometrium
Other Sympathetic ganglia (cervical, celiac, sacral ganglia)
Benign condition or disease
Granuloma Granulation tissue, keroid, sarcoidosis, active tuberculosis, anthracosis
Inflammation Nodular fasciitis, bronchiectasis
Bone disorder Paget’s disease, fibrous dysplasia, healing bone fracture
Benign tumor Meningioma, neurogenic tumor (schwannoma), hemangioma of liver, hemangioendothelioma of liver, adrenal adenoma, pancreatic serous cystadenoma, pancreatic neuroendocrine tumor
Soft tissue tumor desmoid tumor, intramuscular myxoma
Other Amyloidosis
Malignant tumor
Brain Glioblastoma multiforme
Head and neck Salivary gland ductal carcinoma, squamous cell carcinoma of oropharynx, thyroid carcinoma
Chest Pulmonary adenocarcinoma, breast carcinoma
Abdomen Hepatocellular carcinoma, renal cell carcinoma, gastrointestinal stromal tumor, urothelial carcinoma, colorectal carcinoma
Hematologic malignancy Malignant lymphoma, multiple myeloma